Enrico Montefusco Selected Research

Enrico Montefusco Research Topics

12	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2016 - 03/2002
4	Neoplasms (Cancer) 09/2020 - 10/2008
4	Acute Promyelocytic Leukemia 03/2014 - 10/2008
3	Multiple Sclerosis 07/2009 - 10/2008
2	Leukemia 12/2019 - 10/2008
1	Essential Thrombocythemia 09/2020
1	Hematologic Diseases (Blood Diseases) 12/2019
1	Iron Overload 01/2019
1	Splenomegaly 03/2016
1	Thrombosis (Thrombus) 03/2016
1	Primary Myelofibrosis (Myelosclerosis) 03/2015
1	Anemia 10/2014
1	Exanthema (Rash) 10/2014
1	Muscle Cramp (Cramp) 10/2014
1	Pericardial Effusion 04/2011
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2009
1	Breast Neoplasms (Breast Cancer) 10/2008
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2008
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2007
1	Philadelphia Chromosome 01/2006

10	Imatinib Mesylate (Gleevec)FDA Link 11/2016 - 03/2005
3	Dasatinib (BMS 354825)FDA Link 01/2013 - 12/2010
3	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2009 - 10/2008
2	Tyrosine Kinase InhibitorsIBA 12/2019 - 06/2011
2	Deferasirox FDA Link 01/2019 - 06/2016
2	Type II DNA Topoisomerases (Topoisomerase II)IBA 03/2009 - 10/2008
2	Interferon-alpha (Interferon Alfa)IBA 01/2006 - 03/2002
1	Pharmaceutical PreparationsIBA 09/2020
1	anagrelide (Agrylin)FDA LinkGeneric 09/2020
1	Ferritins (Ferritin)IBA 01/2019
1	Hemoglobins (Hemoglobin)IBA 03/2015
1	Phosphotransferases (Kinase)IBA 01/2013
1	Arsenic Trioxide (Trisenox)FDA Link 07/2009
1	trioctyl phosphine oxide (TOPO)IBA 03/2009
1	DNA (Deoxyribonucleic Acid)IBA 03/2009
1	Rituximab (Mabthera)FDA Link 01/2007
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2006
1	Proteins (Proteins, Gene)FDA Link 01/2006
1	CytosineIBA 03/2002